News
Delayed cerebral ischemia is a leading complication in the severe form of stroke known as subarachnoid hemorrhage and can result in long-term neurological damage, disability, or death.
An international discovery collaboration is harnessing AI-powered drug discovery to develop a first-in-class therapy to prevent delayed cerebral ischemia in patients with subarachnoid hemorrhage. The ...
Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new study from St. Jude Children's Research Hospital. Many people with sickle ...
Findings from three patients in a gene therapy clinical trial showed that gene therapy treatment significantly improved blood ...
13d
News-Medical.Net on MSNGene therapy shows promise for reducing stroke risk in patients with sickle cell diseaseGene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new ...
Recent study investigates the pathophysiology of hypoxic-ischemic encephalopathy (HIE) in patients following cardiac arrest ...
The pig’s heart was graying rapidly, so McCully decided to try it. He loaded a syringe with the extracted mitochondria and ...
Some symptoms of this type of stroke include sudden weakness, especially on one side of the body, trouble speaking or ...
The outcome and infarction size after focal cerebral ischemia is determined in part by delayed neuronal cell death in the borderzone of ischemia.
University of Utah researchers believe inflammation starts a months-long process that increases risk of aneurysm rupture.
4don MSN
Scientists have discovered novel drug candidates which could ultimately lead to new effective treatments for conditions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results